FUNDING FLAGSHIP 1 ( 2017 - 2020 )
Sydney Vital : $ 815 , 625
External Sources : $ 2 , 125 , 000
23.6%
76.4%
External Sources include : The Mark Hughes Foundation , The Brain Cancer Group , NHMRC , Sutton Family Translational Research grant
RESEARCH SUCCESSES
Pin - pointed the need for close monitoring of haematologic and immune - related adverse events in patients receiving combination immunotherapy and radiotherapy . Demonstrated the prognostic value of systemic inflammatory response biomarkers in colorectal cancer . Revealed an unrecognised deficiency in immune cells following chemotherapy for colorectal cancer that needs to be considered in therapeutic management . Was awarded an additional $ 2 . 1 million in research funding by leveraging the initial funding . Led a special international journal issue dedicated to inflammation in cancer . Established infrastructure utilizing the only small animal research radiation platform ( Xstrahl SARRP ) in Australia for pre - clinical assessment of new therapies in combination with radiation .
P A G E
1 2
Made with FlippingBook - professional solution for displaying marketing and sales documents online